SecBot SecBot
8-K ·Filed Oct 28, 2026

ALGN

ALIGN TECHNOLOGY INC
NEUTRAL
Impact 5/10
Horizonweeks Processed1d 4h ago SEC0001097149-26-000077
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

The Q4 revenue guidance of $1.00B-$1.02B implies a sequential decline from Q3, reflecting management's cautious view on discretionary healthcare spending. Watch for the Q4 2026 earnings call for any change in the 2027 preliminary outlook, which currently assumes no consumer recovery.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Align Technology reported Q3 2026 revenue of $1.015B, up 1.9% YoY, and non-GAAP EPS of $2.80, slightly above the $2.76 consensus. Clear Aligner revenue grew 4.2% YoY with volume up 6.6%, but Imaging Systems revenue fell 7.6% YoY. The company guided Q4 revenue to $1.00B-$1.02B, implying a sequential decline, and maintained full-year 2026 non-GAAP operating margin guidance of 23.7%.

Key Financial Metrics

EPS (Adj.)
$2.80
est $2.76 · +1.4% · GAAP: $1.90
Revenue
$1.0B
est $1.0B · +1.5% · +1.9% YoY
Rating
in line
Guidance
$4.11B-$4.13B
maintained
Gross Margin
68.7%

Key Facts

  • Q3 2026 total revenue $1.0148B, up 1.9% YoY, in line with $1.00B consensus
  • Non-GAAP diluted EPS $2.80 vs consensus $2.76, a beat of +1.4%
  • Clear Aligner revenue $839.3M, up 4.2% YoY; volume 690.6K cases, up 6.6% YoY
  • Imaging Systems and CADCAM Services revenue $175.5M, down 7.6% YoY
  • GAAP gross margin 68.7%; non-GAAP gross margin 70.4% flat YoY
  • GAAP operating margin 16.7% vs 9.7% a year ago; non-GAAP operating margin 24.4% vs 23.9%
  • Q4 2026 revenue guidance $1.00B-$1.02B, implying ~0-2% sequential decline from Q3
  • Full-year 2026 revenue guidance narrowed to $4.11B-$4.13B, up ~2-3% YoY
  • Q3 2026 stock repurchases of 627.3K shares at avg $164.73; $630M remaining under $1B program
  • Expects to repurchase up to $300M in Q4 2026 and ~$500M for full year 2026

Financial Impact

Q3 revenue $1.0148B, non-GAAP EPS $2.80; Q4 guidance $1.00B-$1.02B; FY2026 guidance $4.11B-$4.13B

revenueepsoperating marginclear aligner volume

Segment Breakdown

SegmentRevenueGrowth
Clear Aligner$839.3M+4.2%
Imaging Systems and CADCAM Services$175.5M-7.6%

Risk Factors

  • Imaging Systems revenue declined 7.6% YoY, indicating continued weakness in capital equipment spending
  • Clear Aligner ASP fell to $1,215 in Q3 from $1,260 in Q2, pressuring revenue growth despite volume gains
  • Management cited a 'softer environment for discretionary healthcare spending' persisting through Q3
  • UK VAT contingency accrual of $5.6M in Q3 and $37.5M in Q2 represents ongoing legal/regulatory exposure
  • Foreign exchange headwinds unfavorably impacted revenue by ~0.5% YoY and EPS by $0.24

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
61% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001097149-26-000077
Document: algn-20261028.htm0001097149-26-000077
Document: 0001097149-26-000077-index-headers.html0001097149-26-000077
Document: 0001097149-26-000077-index.html0001097149-26-000077
Document: 0001097149-26-000077.txt0001097149-26-000077
8-K Data (Synthetic)0001097149-26-000077
14 reports for ALGN
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 5 of 6 best @ T+60▲ +12.30%Aug 3, 2026
Filters
Rows
Reports for ALGN, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
8-K
NEUTRAL ★ 3/10
$153.74awaiting T+20awaiting T+20$153.62 (−0.08%)
Oct 28, 2026
1d ago
8-K
NEUTRAL ★ 5/10
$153.74awaiting T+20awaiting T+20$153.62 (−0.08%)
Oct 21, 2026
9d ago
PTAB Trial
MIXED ★ 6/10
$155.51awaiting T+20awaiting T+20$153.62 (−1.22%)
Oct 16, 2026
13d ago
Institutional Cluster
BEARISH ★ 4/10
$148.90awaiting T+20awaiting T+20$153.62 (−3.17%)
Aug 31, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$154.96 $145.35▼ −6.20%▼ −6.52%$153.62 (−0.86%)
Aug 10, 2026
11w ago
Court Ruling
BEARISH ★ 5/10
$172.96 $152.92▲ +11.58%▲ +10.53%$153.62 (+11.18%)
Aug 3, 2026
12w ago
Institutional Cluster
BEARISH ★ 5/10
$173.27 $154.96▲ +10.57%▲ +9.33%$153.62 (+11.34%)
Jul 21, 2026
14w ago
Court Ruling
BULLISH ★ 6/10
$172.46 $163.04▼ −5.46%▼ −8.36%$153.62 (−10.92%)
Jul 7, 2026
16w ago
Court Ruling
BULLISH ★ 5/10
$174.68 $174.83▲ +0.09%▼ −3.19%$153.62 (−12.06%)
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$173.76 $176.76▲ +1.73%▲ +1.87%$153.62 (−11.59%)
Showing 10 of 14

US Market Status

Market Closed · Opens Mon (60h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026